Yukihiro Shiga Selected Research

Open-Angle Glaucoma (Glaucoma, Open Angle)

1/2021	Time-Course Changes in Optic Nerve Head Blood Flow and Retinal Nerve Fiber Layer Thickness in Eyes with Open-angle Glaucoma.
8/2017	Relationship between laser speckle flowgraphy and optical coherence tomography angiography measurements of ocular microcirculation.
1/2017	Age- and sex-dependency of the association between systemic antioxidant potential and glaucomatous damage.
1/2017	The Effect of Systemic Hyperoxia on Optic Nerve Head Blood Flow in Primary Open-Angle Glaucoma Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukihiro Shiga Research Topics

Disease

20	Glaucoma 01/2021 - 06/2013
6	Ganglion Cysts (Ganglion) 10/2020 - 11/2013
5	Low Tension Glaucoma 09/2017 - 12/2014
4	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2021 - 01/2017
3	Inflammation (Inflammations) 12/2021 - 01/2017
3	Hyperoxia 09/2020 - 01/2015
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 01/2014
3	Blister (Bulla) 12/2019 - 02/2015
2	Retinal Vein Occlusion 01/2020 - 01/2014
2	Cicatrix (Scar) 12/2019 - 02/2015
1	Neuroinflammatory Diseases 12/2021
1	Neoplasms (Cancer) 09/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2020
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2020
1	Ischemia 01/2020
1	Reperfusion Injury 01/2020
1	Genetic Risk Score 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Bradycardia 05/2018
1	Atrophy 05/2018
1	Optic Nerve Injuries 06/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2014
1	Macular Edema 01/2014

Drug/Important Bio-Agent (IBA)

10	Retinaldehyde (Retinal)IBA 12/2021 - 11/2013
4	Biomarkers (Surrogate Marker)IBA 09/2020 - 02/2016
3	HesperidinIBA 12/2021 - 01/2017
2	N-Methylaspartate (NMDA)IBA 12/2021 - 01/2017
2	Neuroprotective AgentsIBA 12/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 10/2014
2	AntioxidantsIBA 01/2021 - 01/2017
2	Oxygen (Dioxygen)IBA 09/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2019
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 12/2019 - 01/2019
2	tafluprostIBA 01/2017 - 06/2013
1	CytokinesIBA 12/2021
1	trans-sodium crocetinate (crocetin)IBA 01/2021
1	TabletsIBA 01/2021
1	RecoverinIBA 09/2020
1	AntibodiesIBA 09/2020
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2020
1	Pyruvic Acid (Pyruvate)IBA 01/2020
1	Oxidoreductases (Dehydrogenase)IBA 01/2020
1	Amsacrine (AMSA)IBA 12/2019
1	Topoisomerase II InhibitorsIBA 12/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Colchicine FDA LinkGeneric 01/2019
1	SteroidsIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 06/2017
1	Syntex adjuvant formulationIBA 01/2017
1	Biological ProductsIBA 01/2017
1	CalpainIBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	rho-Associated KinasesIBA 10/2014
1	K-115IBA 10/2014
1	Bevacizumab (Avastin)FDA Link 01/2014

Therapy/Procedure

12	Lasers (Laser) 10/2020 - 01/2014
3	Trabeculectomy (Trabeculoplasty) 12/2019 - 02/2015
1	Filtering Surgery 12/2019
1	Intravitreal Injections 01/2014